ASP Isotopes announces Quantum Leap, Necsa advance collaboration

ASP Isotopes (ASPI) announced that on February 20, 2026, a South African subsidiary of Quantum Leap Energy and the South African Nuclear Energy Corporation, Necsa, executed a Pre-Implementation Services Contract Agreement as part of the planned collaboration on the research, development and ultimately commercial production of High Assay Low Enriched Uranium, HALEU, marking a critical step forward in addressing global nuclear fuel supply needs for next generation fission reactors. “This milestone represents a significant advancement in our commercial partnership with Necsa and its proven infrastructure for the development of nuclear materials,” said Ryno Pretorius, CEO of Quantum Leap Energy. “Gaining access to this internationally-recognized facility is intended to help us to move from planning to implementation, and advance our goal of providing a reliable HALEU supply for next-generation reactors to meet rapidly growing market demand for HALEU nuclear fuel.”